A live-attenuated chlamydial vaccine protects against trachoma in nonhuman primates

Number of Years of Annual Mass Treatment With Azithromycin Needed to Control Trachoma in Hyper-endemic Communities in Tanzania

(2011) Sheila K. West et al.   JOURNAL OF INFECTIOUS DISEASES

Association of tubal factor infertility with elevated antibodies to Chlamydia trachomatis caseinolytic protease P

(2010) Allison K. Rodgers et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Frameshift Mutations in a Single Novel Virulence Factor Alter the In Vivo Pathogenicity of Chlamydia trachomatis for the Female Murine Genital Tract

(2010) G. L. Sturdevant et al.   INFECTION AND IMMUNITY

A Genome-Wide Profiling of the Humoral Immune Response to Chlamydia trachomatis Infection Reveals Vaccine Candidate Antigens Expressed in Humans

(2010) J. Wang et al.   JOURNAL OF IMMUNOLOGY

Chlamydia trachomatis Native Major Outer Membrane Protein Induces Partial Protection in Nonhuman Primates: Implication for a Trachoma Transmission-Blocking Vaccine

(2009) L. Kari et al.   JOURNAL OF IMMUNOLOGY

Reduction and Return of Infectious Trachoma in Severely Affected Communities in Ethiopia

(2009) Takele Lakew et al.   PLoS Neglected Tropical Diseases

The Chlamydia trachomatis Plasmid Is a Transcriptional Regulator of Chromosomal Genes and a Virulence Factor

(2008) J. H. Carlson et al.   INFECTION AND IMMUNITY

Pathogenic Diversity amongChlamydia trachomatisOcular Strains in Nonhuman Primates Is Affected by Subtle Genomic Variations

(2008) Laszlo Kari et al.   JOURNAL OF INFECTIOUS DISEASES